Assessment reveals gentamicin-loaded bone cement enhances biocompatibility, preventing Escherichia coli growth in vivo.
The present article describes the fabrication of a bioresorbable, antibacterial bone cement comprising carbonate apatite (CO₃Ap) and gentamicin sulfate (GNT). We focused on a fast-setting CO₃Ap cement using vaterite and monetite as raw powders and Na₂HPO₄ as a mixing solution, to which we added GNT. The initial setting time, physical properties, drug release property, antibacterial property, and in vivo bioresorbability and biocompatibility of the CO₃Ap cements were evaluated. The addition of GNT decreased the initial setting time without affecting the other physical properties of the set cements. Moreover, the GNT-loaded CO₃Ap cements demonstrated potential for drug sustained-release and prevented the growth of Escherichia coli. In vivo studies, the cement formed osteoconductive connections with the bone-like tissues in rat tibia; however, delayed bioresorption was observed. Based on these results, we conclude that GNT-loaded CO₃Ap cements that reduce the risk of surgical site infection are potential candidates for bioabsorbable bone cement.
No takes yet. Share an insight, caveat, or question.
Shigematsu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: